Identification of TUBB3 as an immunotherapy target in lung cancer by genome wide in vivo CRISPR screening
Recent development of immune checkpoint inhibitors has revolutionized cancer immunotherapy. Although these drugs show dramatic effects on a subset of cancer patients, many other tumors are non-responsive and the pathological mechanism of the resistance is largely unknown. To identify genes underlyin...
Saved in:
Main Authors: | Dan Zhao, Ravindra Deshpande, Kerui Wu, Abhishek Tyagi, Sambad Sharma, Shih-Ying Wu, Fei Xing, Stacey O'Neill, Jimmy Ruiz, Feng Lyu, Kounosuke Watabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558624001416 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathogenic variants of TUBB8 cause oocyte spindle defects by disrupting with EB1/CAKP5 interactions and potential treatment targeting microtubule acetylation through HDAC6 inhibition
by: Hui Luo, et al.
Published: (2025-01-01) -
Production of novel theranostic nano-vector based on superparamagnetic iron oxide nanoparticles/miR-497 targeting colorectal cancer
by: Asmaa M. Elfiky, et al.
Published: (2025-02-01) -
Establishment of a Rapid and Convenient Fluoroimmunoassay Platform Using Antibodies Against PDL1 and HER2
by: Ji Eun Choi, et al.
Published: (2025-01-01) -
Clinical, histopathological and immunohistochemical analysis of vulvar squamous cell carcinoma
by: Lorenza Bridi Todeschini, et al.
Published: (2025-01-01) -
Increased serum soluble PD-l1 levels in patients with advanced stages of chronic kidney disease
by: Ayaka Hayashi, et al.
Published: (2025-01-01)